HD-OPM Archive
Topics › Statins

Statins activate AMPK via mild mitochondrial stress, which Louis argues is beneficial

Louis Nervegna · Nov 23, 2023 · ♥ 19 reactions · 12 comments · original Facebook post
StatinsAging & longevityBlood vessels, circulation & endothelium
AI summary & key facts

Louis argues statins do not harmfully impair mitochondria; instead, like metformin, they mildly stress mitochondria and activate the longevity-linked AMPK pathway (mitohormesis), possibly contributing to cardiovascular benefit. He cites a 2006 Circulation study showing statins activate AMPK in vitro and in vivo, leading to endothelial NO synthase activation. The extension to lifespan and mitohormesis is his interpretation.

Statins do not impair mitochondrial function in a harmful way. This is nonsense.

In fact, it is the opposite. The mild stress that they put on mitochondria may be one of the reasons why they are good for you.

Just like metformin, statins activate an important longevity pathway called AMPK by inducing hormetic stress in mitochondria. This may be one of multiple reasons why statins (and metformin) benefit the cardiovascular system.

The term for this kind of mitochondrial hormetic stress is mitohormesis. Google it. Mitohormesis has many health benefits.

If you understand the most important papers in geroscience (the science of aging), you know that mildly impairing mitochondrial function is often a good thing. This can be an example of hormetic stress, and it is exactly what metformin does. When mitochondrial function is impaired by metformin, defensive pathways such as AMPK are turned on which extend lifespan in lower animals. In this way, metformin acts like a calorie restriction mimetic, a drug that mimics the life extending benefits of calorie restriction.

These defensive pathways are energy sensors. When they sense that energy in the mitochondria is low they turn on, because low energy in the mitochondria usually indicates calories are restricted. By mildly impairing mitochondrial function, statins (and metformin) lower energy in the mitochondria, and as a result, the AMPK defensive pathway gets turned on. Like metformin, statins also extend lifespan in lower animals. Hormetic mitochondrial stress is probably one of the mechanisms by which statins also extend lifespan in lower animals— it is probably a good thing.

Obviously if you overdo it, then it can cause harm, but as long as the doses are reasonable, this hormetic mitochondrial stress (mitohormesis) is likely good for you.

#statinsHD #mitochondriaHD #hormesisHD #mitohormesisHD #ampkHD #metforminHD

Paper · Circulation · 2006Statins activate AMP-activated protein kinase in vitro and in vivo.Conclusion: Statins can rapidly activate AMPK via increased Thr-172 phosphorylation in vitro and in vivo. Such phosphorylation results in endothelial NO synthase activation, which provides a novel explanation for the pleiotropic effects of statins that benefit the cardiovascular system.pubmed.ncbi.nlm.nih.gov

Research cited

← newer: Generic statins are nearly free: 3 months of atorvastatin 20older: Seventeen modifiable heart-disease risk factors: target as m →